Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its proprietary cell-based therapy platform and associated development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally-differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical assets include (i) OpRegen®, a retinal pigment epithelium transplant therapy in Phase I/IIa development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase I/IIa development for the treatment of acute spinal cord injuries; and (iii) VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells currently in Phase I development for the treatment of non-small cell lung cancer. For more information, please visit www.lineagecell.com.
Company Details
- Employees
- 32
- Founded
- -
- Address
- 2173 Salk Avenue,
- Phone
- 510-521-3390
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- lineagecell.com
- Keywords
- Engineer jobs.
- HQ
- Carlsbad, CA
Lineage Cell Therapeutics Questions
Lineage Cell Therapeutics's helpline number is 510-521-3390
Lineage Cell Therapeutics's website is lineagecell.com
Lineage Cell Therapeutics's LinkedIn profile is https://www.linkedin.com/company/lineagecell
Lineage Cell Therapeutics has
32 employees.
View email and phone details for 32
employees at Lineage Cell Therapeutics.
Lineage Cell Therapeutics's industry is
Biotechnology Research
Lineage Cell Therapeutics's top competitors are
Ncardia,
Alloy Therapeutics, Inc.,
Cellistic,
Swarm Oncology,
Capsida Biotherapeutics,
Immunis, Inc.,
Newbiologix,
Solvias,
Cell Cure Neurosciences Ltd.,
Biora Therapeutics.
Lineage Cell Therapeutics's categories are Biotechnology Research
Lineage Cell Therapeutics's founding year is 1990
